Luminex Corporation To Present At Leerink Swann Global Healthcare Conference

 Luminex Corporation To Present At Leerink Swann Global Healthcare Conference

PR Newswire

AUSTIN, Texas, Jan. 31, 2013

AUSTIN, Texas, Jan. 31, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ:
LMNX) today announced that management will present at the Leerink Swann Global
Healthcare Conference to be held February 13 -14, 2013, in New York, NY.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

The investor presentation by Patrick J. Balthrop, president and chief
executive officer, will begin at 11:30 a.m. Easterntime on Thursday, February
14, 2013. The presentation will bewebcast live and may be accessed at
Luminex Corporation's website at http://www.luminexcorp.com. Simplylog on to
the web at the address above, go to the Company section and access the
Investor Relations link. Please go to the website at least 15 minutes prior to
the event to register, download and install any necessary audio/video
software. If you are unable to participate during the live webcast, the
presentation will be archived for six months on the website using the 'replay'
link.

ABOUT LUMINEX CORPORATION

Luminex is committed to applying its passion for innovation toward advancing
healthcare and research worldwide. The Company is transforming global
healthcare and life-science research through the development, manufacturing
and marketing of proprietary instruments and assays utilizing xMAP^®
open-architecture, multi-analyte platform and MultiCode^® real-time polymerase
chain reaction (PCR) and multiplex PCR-based technologies, that deliver
cost-effective and rapid results to clinicians and researchers. Luminex's
technology is commercially available worldwide and in use in leading clinical
laboratories as well as major pharmaceutical, diagnostic, biotechnology and
life-science companies. The Company is meeting the needs of customers in
markets as diverse as clinical diagnostics, pharmaceutical drug discovery,
biomedical research including genomic and proteomic research, personalized
medicine, bio-defense research and food safety. For further information on
Luminex Corporation and the latest advances in multiplexing using award
winning technology, please visit http://www.luminexcorp.com.

Contacts: Harriss T. Currie
          Chief Financial Officer
          Vice President Finance
          512-219-8020
          Matthew Scalo
          Sr. Director of Investor Relations
          512-219-8020
          mscalo@luminexcorp.com

SOURCE Luminex Corporation

Website: http://www.luminexcorp.com